Literature DB >> 10213720

Cyclosporin neurotoxicity after chemotherapy.

D A Tweddle1, K P Windebank, Q C Hewson, S M Yule.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10213720      PMCID： PMC27845          DOI： 10.1136/bmj.318.7191.1113

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Cyclosporin A used to reverse drug resistance increases vincristine neurotoxicity.

Authors:  Y Bertrand; R Capdeville; N Balduck; N Philippe
Journal:  Am J Hematol       Date:  1992-06       Impact factor: 10.047

2.  Mechanisms of cyclophosphamide action on hepatic P-450 expression.

Authors:  G A LeBlanc; D J Waxman
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

3.  Convulsions associated with cyclosporin A.

Authors:  D P O'Sullivan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-16

4.  Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.

Authors:  D E Reece; D A Frei-Lahr; J D Shepherd; K Dorovini-Zis; R D Gascoyne; D A Graeb; J J Spinelli; M J Barnett; H G Klingemann; G P Herzig
Journal:  Bone Marrow Transplant       Date:  1991-11       Impact factor: 5.483

5.  Cyclosporine-associated seizures in bone marrow transplant recipients given busulfan and cyclophosphamide preparative therapy.

Authors:  A M Ghany; P J Tutschka; R B McGhee; B R Avalos; I Cunningham; N Kapoor; E A Copelan
Journal:  Transplantation       Date:  1991-08       Impact factor: 4.939
  5 in total
  1 in total

1.  Cyclosporin neurotoxicity after chemotherapy. Case had features of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.

Authors:  G Pratt; B Kennedy; G Smith
Journal:  BMJ       Date:  1999-07-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.